A Swiss biotech company
based in Basel
Our strategy
is built upon
two main pillars.
Designing and developing best-in-class vaccines.
Our expertise and technologies enable us to create vaccines that, we believe, will outperform any other commercial or in-development vaccine in several disease areas.Developing an advanced technology platform specifically for vaccine design.
Our primary goal is to leverage our reverse genetic engineering expertise to create next-generation vaccines that significantly outperform existing options. We have carefully studied the competitive landscape and thoroughly analyzed various diseases to develop innovative vaccines using our state-of-the-art technologies, with the aim of achieving a superior market position for our products.RocketVax utilizes proprietary reverse genetic engineering & molecular biology technologies to develop innovative, next-generation vaccines.
Our first products are
COVID-19 vaccines, which possess the following characteristics
Long-lasting immunity
Effectiveness against circulating & future SARS-CoV-2 variants
Needle-free, intranasal vaccine administration
Cost-efficient manufacturing
Stable vaccine formulation
Effective booster
Rapid adaptability
RocketVax vaccine
product overview and differentiation
CURRENT CHALLENGES
Vulnerable to virus mutations
The constantly mutating nature of SARS-CoV-2 reduces the efficacy of first-generation vaccines.Short-term immune protection
First-generation vaccines induce antibodies against only the Spike protein and the protection they provide wanes rapidly.Infection of immunized individuals
First-generation vaccines offer poor protection against new infections and are ineffective in preventing the transmission and spread of the virus.Limited stability at higher temperatures
The instability of mRNA vaccines at higher temperatures necessitates complex logistics for their storage and distribution.RocketVax SOLUTIONS
Resilience to virus mutations
Live-attenuated SARS-CoV-2 vaccines protect against virus variants and mutations by generating broad immune responses.Long-lived systemic and local immunity
Our vaccines provide long-lasting protection by generating antibody, T-cell, and mucosal responses against all virus proteins.Nasal formulation prevents re-infection
Our vaccine mimics the natural route of infection through nasal vaccination, which helps prevent re-infection and limits the spread of the virus.Stability and prolonged shelf-life
The stability of live-attenuated SARS-CoV-2 vaccines allows our vaccine to be stored at regular temperatures and easily distributed worldwide.The RocketVax vaccine possesses all the characteristics necessary for successful prevention of COVID-19.
